Product
ATSN-201
1 clinical trial
1 indication
Indication
X-linked retinoschisisClinical trial
A Phase 1/2, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety and Tolerability of ATSN-201 Gene Therapy in Male Subjects With RS1-Associated X-linked RetinoschisisStatus: Recruiting, Estimated PCD: 2025-10-01